JueJSMikhailDGonzálezJAlameddineM.Assessment of renal function in transgender patients with kidney disease. Can J Kidney Health Dis. 2021;8:20543581211020170. doi:10.1177/20543581211020168.
2.
WebbAJMcManusDRouseGEVonderheydeRTopalJE.Implications for medication dosing for transgender patients: a review of the literature and recommendations for pharmacists. Am J Health Syst Pharm. 2020;77(6):427-433. doi:10.1093/ajhp/zxz355.
3.
MaheshwariADinesVSaulDNippoldtTKattahADavidge-PittsC.The effect of gender-affirming hormone therapy on serum creatinine in transgender individuals. Endocr Pract. 2021;28(1):52-57. doi:10.1016/j.eprac.2021.08.009.
4.
CollisterDSaadNChristieEAhmedS.Providing care for transgender persons with kidney disease: A narrative review. Can J kidney Health Dis. 2021;8:2054358120985379. doi:10.1177/2054358120985379.
5.
FadichSKKalayjianAGreeneDNCirrincioneLR.A retrospective analysis of creatinine-based kidney function with and without sex assigned at birth among transgender adults. Ann Pharmacother. 2022;56(7):791-799. doi:10.1177/10600280211050120.
6.
JueJSAlameddineMCiancioG.Kidney transplantation in transgender patients. Curr Urol Rep. 2020;21(1):1. doi:10.1007/s11934-020-0953-x.
7.
StevensLACoreshJSchmidCH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395-406. doi:10.1053/j.ajkd.2007.11.018.
8.
TeafordHRBarretoJNVollmerKJRuleADBarretoEFCystatinC.A primer for pharmacists. Pharmacy (Basel, Switzerland). 2020;8(1). doi:10.3390/pharmacy8010035.
9.
InkerLAEneanyaNDCoreshJ, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953.
